Table 1.
General characteristics | Total cases n (%) |
Imported cases n (%) | Secondary cases n (%) |
---|---|---|---|
Total | 69 | 46 | 23 |
Sex | |||
Male | 35(50.72 %) | 26(56.52 %) | 9(39.13 %) |
Female | 34(49.28 %) | 20(43.48 %) | 14(60.87 %) |
Age group(year) | |||
0- | 3(4.35 %) | 1(2.17 %) | 2(8.70 %) |
10- | 7(10.14 %) | 7(15.22 %) | 0(0) |
20- | 9(13.04 %) | 8(17.39 %) | 1(4.35 %) |
30- | 10(14.49 %) | 7(15.22 %) | 3(13.04 %) |
40- | 10(14.49 %) | 7(15.22 %) | 3(13.04 %) |
50- | 16(23.19 %) | 8(17.39 %) | 8(34.78 %) |
60- | 7(10.14 %) | 4(8.70 %) | 3(13.04 %) |
70- | 5(7.25 %) | 3(6.52 %) | 2(8.70 %) |
≥80 | 2(2.90 %) | 1(2.17 %) | 1(4.35 %) |
Exposure history | |||
Travel or residence history in Hubei | 24(34.78 %) | 24(52.17 %) | – |
Travel or residence history in other regions except Hubei | 22(31.88 %) | 22(47.83 %) | – |
Contact with other people with a history of travelling or residence history in Hubei or other regions | 14(20.29 %) | – | 14(60.87 %) |
History of exposure to locally confirmed cases or asymptomatic infections | 9(13.04 %) | – | 9(39.13 %) |
Underlying diseases | |||
Yes | 27(39.13 %) | 15(32.61 %) | 12(52.17 %) |
No | 42(60.87 %) | 31(67.39 %) | 11(47.83 %) |
Clinical severity* | |||
Asymptomatic | 10(14.49 %) | 4(8.70 %) | 6(26.10 %) |
Mild | 17(24.64 %) | 10(21.74 %) | 7(30.43 %) |
Normal | 35(50.72 %) | 26(56.50 %) | 9(39.10 %) |
Severe | 5(7.25 %) | 4(8.70 %) | 1(4.35 %) |
Critical | 2(2.90 %) | 2(4.35 %) | 0(0) |
Patients were classified by their most severe status as of March 2, 2020. There may be cases where the composition ratio is not 1 due to rounding.